The Effect of Transcutaneous Vagus Nerve Stimulation in Patients with Polymyalgia Rheumatica

(1) Polymyalgia rheumatica (PMR) is an inflammatory disease characterised by pain, morning stiffness, and reduced quality of life. Recently, vagus nerve stimulation (VNS) was shown to have anti-inflammatory effects. We aimed to examine the effect of transcutaneous VNS (t-VNS) on PMR. (2) Fifteen tre...

Full description

Bibliographic Details
Published in:	Pharmaceuticals
Main Authors:	Jacob Venborg, Anne-Marie Wegeberg, Salome Kristensen, Birgitte Brock, Christina Brock, Mogens Pfeiffer-Jensen
Format:	Article
Language:	English
Published:	MDPI AG 2021-11-01
Subjects:	polymyalgia rheumatica vagus nerve stimulation inflammatory response PMR t-vns
Online Access:	https://www.mdpi.com/1424-8247/14/11/1166

Similar Items

Tuberculosis masquerading as polymyalgia rheumatica
by: Kamal Kishore Pandita, et al.
Published: (2015-01-01)

Did the first description of patients with polymyalgia rheumatica take place in Scotland or in Denmark?
by: C. Manzo, et al.
Published: (2024-03-01)

Development and evaluation of disease-specific patient-reported outcome measures questionnaire for polymyalgia rheumatica: validity, reliability, and responsiveness
by: Yasser El Miedany, et al.
Published: (2025-04-01)

Prognosis and management of polymyalgia rheumatica
by: Diana Samara
Published: (2016-02-01)

Prognosis and management of polymyalgia rheumatica
by: Diana Samara
Published: (2011-04-01)

POLYMYALGIA RHEUMATICA
by: A. M. Satybaldyev, et al.
Published: (2018-05-01)

Presentaties van polymyalgia rheumatica bij oudere patienten
by: Rianne Lindeboom, et al.
Published: (2015-06-01)

Polymyalgia rheumatica during the course of limited cutaneous scleroderma: an unusual and challenging coexistence
by: Noel Lorenzo-Villalba, et al.
Published: (2024-07-01)

Polymyalgia Rheumatica Treated with Sarilumab
by: Anvitha Madhavaram, et al.
Published: (2023-12-01)

REVIEW OF RECOMMENDATIONS FOR THE MANAGEMENT OF POLYMYALGIA RHEUMATICA (ACR/EULAR 2015)
by: M. T. Vatutin, et al.
Published: (2016-03-01)

Vascular-adhesion protein 1 in giant cell arteritis and polymyalgia rheumatica
by: Simon M. Petzinna, et al.
Published: (2024-08-01)

Contribution of the new 2012 EULAR/ACR classification criteria for the diagnosis of polymyalgia rheumatica
by: F. Muratore, et al.
Published: (2018-03-01)

Imaging in polymyalgia rheumatica
by: N. Possemato, et al.
Published: (2018-03-01)

Paraneoplastic Polymyalgia Rheumatica as Manifestation of a Pancreatic Neuroendocrine Tumour
by: Luís Felipe Linhares Santos, et al.
Published: (2014-11-01)

Diagnostic approach to polymyalgia rheumatica – own experience
by: Marcin Milchert, et al.
Published: (2014-06-01)

A case of inflammatory pseudotumor of the lung presenting as polymyalgia rheumatica
by: Erin L. Tompkins, et al.
Published: (2019-08-01)

Polymyalgia Rheumatica and Seronegative Elderly-Onset Rheumatoid Arthritis: Two Different Diseases with Many Similarities
by: Ciro Manzo, et al.
Published: (2019-09-01)

A Movement Classification of Polymyalgia Rheumatica Patients Using Myoelectric Sensors
by: Anthony Bawa, et al.
Published: (2024-02-01)

Case Report and Literature Review of an Atypical Polymyalgia Rheumatica and Its Management
by: Ahmed SB, et al.
Published: (2023-12-01)

The real evidence for polymyalgia rheumatica as a paraneoplastic syndrome
by: S. Muller, et al.
Published: (2018-03-01)

Polymyalgia Rheumatica: Clinical Features and Third Month Treatment Responses-A Single-Center Experience
by: Mert Öztaş
Published: (2025-05-01)

Is it correct to attribute the first description of Polymyalgia Rheumatica to Dr. William Bruce?
by: C. Manzo, et al.
Published: (2023-12-01)

Water vapor therapy and polymyalgia rheumatica: Coincidental?
by: Joshua Lee, et al.
Published: (2023-11-01)

The role of the general practitioner and the out-of-hospital public rheumatologist in the diagnosis and follow-up of patients with polymyalgia rheumatica
by: A. Sobrero, et al.
Published: (2018-03-01)

Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with Polymyalgia Rheumatica: a narrative review
by: Stig Tengesdal, et al.
Published: (2024-11-01)

Low incidence of malignancy in patients with suspected polymyalgia rheumatica or giant cell arteritis, examined with FDG-PET/CT
by: Tanja Fromberg Gorlen, et al.
Published: (2024-02-01)

The evolution of diagnosis of polymyalgia rheumatica
by: A. M. Satybaldyev
Published: (2019-12-01)

Polymyalgia rheumatica following respiratory syncytial virus (RSV) vaccination
by: Mohamad El Labban, et al.
Published: (2024-06-01)

Polymyalgia Rheumatica Presenting as Nocturnal Pyrexia of Unknown Origin: A Case Report
by: Nauman Ismat Butt, et al.
Published: (2024-06-01)

Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
by: Ciro Manzo, et al.
Published: (2021-02-01)

Bilateral Pubic Ramus Insufficiency Fracture in Patient with Diagnosed Polymyalgia Rheumatica
by: Hamza Sucuoğlu, et al.
Published: (2012-04-01)

Infective agents and polymyalgia rheumatica: key discussion points emerging from a narrative review of published literature
by: Ciro Manzo, et al.
Published: (2024-11-01)

Update on treatment of polymyalgia rheumatica
by: D. Camellino, et al.
Published: (2018-03-01)

Efficacy and Safety of Biologics in Polymyalgia Rheumatica: A Retrospective Study
by: Naoaki Ohkubo, et al.
Published: (2024-08-01)

After what time interval are we justified to diagnose immune checkpoint inhibitor-mediated polymyalgia rheumatica?
by: Ciro Manzo, et al.
Published: (2025-03-01)

Red cell distribution width is a potential predictor of early relapse in polymyalgia rheumatica
by: D. Soddu, et al.
Published: (2021-08-01)

(Dis)agreement of polymyalgia rheumatica relapse criteria, and prediction of relapse in a retrospective cohort
by: Thomas E. Bolhuis, et al.
Published: (2022-08-01)

The fast-track outpatient clinic significantly decreases hospitalisation rates among polymyalgia rheumatica patients
by: Stavros Chrysidis, et al.
Published: (2021-10-01)

Choroidal thickness as a biomarker of systemic inflammation in patients with polymyalgia rheumatica
by: Laura Trives-Folguera, et al.
Published: (2025-10-01)

Elderly-onset rheumatoid arthritis vs. polymyalgia rheumatica: Differences in pathogenesis
by: Jinzhi Wu, et al.
Published: (2023-01-01)